Energica Motorcycles Rescued by Singaporean Investors in Surprise Move
Energica Motorcycles
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/9586/259289_energica-ego-1_2022-mobile.jpg
The new investors, whose identities have not yet been publicly disclosed, are said to be passionate followers of the Energica legacy and are committed to restoring the company's position in the global electric mobility market. The move has been welcomed by industry observers and brand loyalists alike, who see the acquisition as a lifeline for a company known for innovation, engineering excellence, and sustainable performance.
In a recent video update, Energica's leadership confirmed that the current management team will remain in place under the new ownership. This decision is intended to ensure operational continuity, protect the brand's long-standing engineering ethos, and keep development of its next-generation electric motorcycles on track.
"We're thrilled to retain the same passionate team that helped make Energica a recognized name in electric performance motorcycles," the company shared. "This transition isn't the end of the road - it's a fresh start. We remain fully committed to our customers, our community, and the mission to lead the future of electric mobility."
Energica Motorcycles
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/9586/259289_energica-ego-2_2022.jpg
The judicial sale process, a form of legal restructuring, is expected to be finalized within the next 60 days. During this period, the company will begin implementing strategic steps to stabilize and strengthen its operations. According to insiders, Energica will prioritize rebuilding relationships with distributors and commercial partners, reestablishing supply chain consistency, and reinforcing customer support channels.
The new ownership group is also expected to inject fresh capital and potentially expand the company's reach in key global markets, particularly in Asia, where demand for high-end electric two-wheelers is rising.
Energica, based in Modena - a region globally revered for Italian automotive craftsmanship - is known for producing premium electric motorcycles that combine speed, sustainability, and cutting-edge technology. With this acquisition, the company appears poised to regain its momentum and play a significant role in the next era of electric transportation.
About Energica Motor Company
Energica is an Italian manufacturer of high-performance electric motorcycles. The company has built a global reputation for producing sustainable, technologically advanced two-wheelers that offer both exhilarating performance and environmental responsibility.
Visit: https://youtu.be/J8I88omOnLo
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
7 hours ago
- Globe and Mail
Did Joby Aviation Just Make a Killer Deal, or Is Blade a Lemon?
Key Points Joby is buying Blade's air mobility business for up to $125 million. The news added nearly $3 billion in market cap to Joby. The eVTOL company is still not earning material revenue. 10 stocks we like better than Joby Aviation › Joby Aviation (NYSE: JOBY) delighted investors on Monday when it announced the acquisition of Blade Air Mobility 's (NASDAQ: BLDE) passenger business. The move gives Joby ownership of what might be the best-known brand in the urban air taxi mobility market. According to the terms of the deal, Joby will pay Blade in up to $125 million in a combination of cash or stock, according to Joby's choosing. The move will give Joby immediate market access in New York City and Southern Europe, as well as ownership of a business that flew more than 50,000 passengers in 2024, primarily in the New York City area. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Investors loved the agreement, sending Joby stock up 18.8% on Monday, which represented a $2.7 billion gain in market cap. For a price of $125 million, that's an incredible return on investment, at more than 20 times. However, investors seemed to have second thoughts about the deal on Tuesday, as both stocks pulled back following Blade's second-quarter earnings report. Joby was down 5% in afternoon trading on Tuesday, while Blade, after jumping 17.2% on Monday, was down 10.8% at the same time. Are investors reading the deal correctly here? Let's take a closer look. What Blade means for Joby It's easy to see the appeal of Blade for Joby and its investors: Blade has an existing urban air taxi network. Joby wants to launch them. The deal does not include Blade's medical division, which will remain a separate publicly traded company renamed Strata Critical Medical, but the two companies are partnering in the medical transportation field, as Joby will become Blade's preferred VTOL partner for Blade's organ transport business. However, there seems to be a disconnect between the $125 million price that Joby is paying Blade and the nearly $3 billion boost it got in its market cap. The fact that Blade stock jumped also indicates that Blade investors believe they got a good price in the sale. Blade's second-quarter earnings report indicates why the company didn't value the air taxi business very highly. In the second quarter, revenue fell 13.2% to $25.7 million, due in part to its exit from the Canadian market, and the short-distance segment, which appears to be what Joby is most interested in, also saw reduced demand due to a helicopter accident in New York in April. Passenger segment adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) improved from $0.8 million to $2.4 million, though that doesn't include corporate costs. Are eVTOL stocks in a bubble? While the Blade deal makes sense for Joby, as it will help boost its ambitions in the urban air taxi market, the market's reaction seems unjustified and is just the latest evidence that electric vertical takeoff and landing (eVTOL) aircraft are in a bubble. Joby is still a development-stage company with no material revenue, yet its market cap has ballooned to more than $16 billion. That makes it more valuable than both American Airlines and Southwest Airlines, two well-established, profitable airlines. In fact, they're two of the four biggest airlines in the country. By bidding up stocks like Joby and Archer Aviation, investors seem to be grossly overestimating the market for air travel and the profit potential in the industry, as Blade's relatively small size shows. Blade's experience also shows that the constraints to scaling an urban air mobility business aren't the advanced technology that eVTOLs provide, such as being emission-free, quieter, or safer, but price and access, which doesn't really change going from a helicopter to an eVTOL. For comparison, a Blade ride from Manhattan to JFK Airport starts at $195 per seat, meaning it's not price-competitive with a taxi, rideshare, or another form of transportation. With its market cap now at $16 billion, high expectations are baked into Joby Aviation stock even though it's barely made a sale. Investors seem to be taking the wrong lesson from Blade here. Yes, the helicopter operator could help Joby, but it failed to disrupt urban transportation. The same is likely to be true for Joby. Should you invest $1,000 in Joby Aviation right now? Before you buy stock in Joby Aviation, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Joby Aviation wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,563!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,108,033!* Now, it's worth noting Stock Advisor's total average return is 1,047% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025
Globe and Mail
18 hours ago
- Globe and Mail
Femasys Revenue Jumps 85 Percent in Q2
Key Points Revenue surged 84.8% to $0.41 million (GAAP) in Q2 2025, far outpacing consensus estimates (GAAP) but still early-stage in scale. FemBloc gained its first-ever European approval; FemaSeed and FemVue secured new regulatory clearances and partnerships. Net loss (GAAP) narrowed slightly to $4.59 million, while cash reserves (GAAP) dropped to $3.22 million, bringing a near-term cash crunch. These 10 stocks could mint the next wave of millionaires › Femasys (NASDAQ:FEMY), a women's health medical technology firm developing permanent birth control and fertility solutions, released its second quarter 2025 results on August 8, 2025. The earnings report was marked by strong revenue growth to $0.41 million (GAAP)—an 84.8% jump in GAAP sales from the prior year period—driven by accelerating early-stage sales of FemaSeed intratubal insemination devices and FemVue diagnostic systems. This figure (GAAP revenue of $409,268) came in far above analyst estimates. The company posted a GAAP net loss of $4.59 million, a slight improvement from the $4.68 million GAAP net loss in Q2 2024. Diluted earnings per share (GAAP) was slightly better than analyst estimates at $(0.16). Despite clear commercial and regulatory progress, continued operating losses and a $3.22 million cash balance as of June 30, 2025 mean Femasys will need additional funding within the next quarter to sustain operations. Source: Analyst estimates for the quarter provided by FactSet. Femasys at a Glance and Business Focus Femasys designs and commercializes non-surgical products for women's reproductive health needs. Its main portfolio spans permanent birth control devices—most notably the FemBloc system—and fertility-related solutions like FemaSeed and FemVue. Recent company focus has been on winning new regulatory approvals, especially for FemBloc, and moving early-stage products from research and development into wider commercial sales. Key success factors for Femasys include clearing regulatory hurdles in each market, gaining adoption from clinics and patients, and forming the right distribution partnerships. Protecting its intellectual property is also essential given the specialized nature of its technology. Quarter Highlights: Financial and Product Progress Revenue (GAAP) climbed 84.8%, driven by sales of FemaSeed and FemVue. A roughly $400,000 order from Spain signals a pivotal step in international expansion efforts. Sales of FemaSeed intratubal insemination devices and FemVue diagnostic products—tools that facilitate fertility assessment—drove most of the top-line gain. Together, these products represent the company's early moves beyond the U.S. market. On the regulatory front, Femasys achieved a series of important clearances: FemBloc received its first European approval, marking the first global regulatory sign-off for a non-surgical permanent birth control option in the company's portfolio. FemaSeed and FemVue also gained approvals in Australia and New Zealand, expanding potential markets and laying groundwork for future sales. Ongoing enrollment in U.S. pivotal trials for FemBloc continues, which will be crucial for future coverage and adoption in the American healthcare market. The company expanded its reach through new partnerships. It announced a relationship with the Carolinas Fertility Institute, an eight-clinic network in the U.S, to offer FemaSeed to more patients. Distribution partnerships in Spain will support further commercialization of FemBloc. Femasys also shored up its patent portfolio, receiving notice of intent to grant new patents in Europe and the U.S. for FemBloc and FemaSeed, maintaining its lead in the emerging non-surgical device category. Financially, the net loss (GAAP) narrowed slightly to $4.59 million, reflecting both increased sales and a 28.4% drop in research and development expense as products transition to the commercial phase. However, cash burn remained high: the $3.22 million cash balance at June 30, 2025 gives the company only enough runway to operate into early fourth quarter, without additional funding. The company raised $4.5 million in new equity but continued operating losses have quickly reduced available resources. Inventory increased 71.8% year-to-date (as of June 30, 2025), showing strategic preparation for expected sales but also a concentration of capital in unsold goods. The share count rose from 23,355,926 as of December 31, 2024, to 32,575,407 as of June 30, 2025. Femasys does not currently pay a dividend. Looking Forward Femasys management did not provide specific revenue or earnings targets for the coming quarters or for fiscal 2025. Leadership emphasized that the next stages will focus on translating recent approvals and pilot orders into routine commercial adoption, particularly in the European Union and new Asia-Pacific markets, and continuing to build distribution and clinic partnerships. Given the current cash position as of June 30, 2025, the company expects its cash and cash equivalents will be sufficient to fund operations into the early fourth quarter of 2025. The expanding international footprint and product pipeline, along with progress on intellectual property protection, remain important areas for investors to monitor in the coming periods. FEMY does not currently pay a dividend. Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,047%* — a market-crushing outperformance compared to 181% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. See the stocks » *Stock Advisor returns as of August 4, 2025
Globe and Mail
a day ago
- Globe and Mail
Energica Motorcycles Rescued by Singaporean Investors in Surprise Move
Modena, Italy--(Newsfile Corp. - August 8, 2025) - In a surprising yet promising development for the electric vehicle industry, renowned Italian electric motorcycle manufacturer Energica Motor Company has been acquired by a group of Singaporean investors. The acquisition follows a judicial sale process and signals a renewed vision for the future of the high-performance electric motorcycle brand. Energica Motorcycles To view an enhanced version of this graphic, please visit: The new investors, whose identities have not yet been publicly disclosed, are said to be passionate followers of the Energica legacy and are committed to restoring the company's position in the global electric mobility market. The move has been welcomed by industry observers and brand loyalists alike, who see the acquisition as a lifeline for a company known for innovation, engineering excellence, and sustainable performance. In a recent video update, Energica's leadership confirmed that the current management team will remain in place under the new ownership. This decision is intended to ensure operational continuity, protect the brand's long-standing engineering ethos, and keep development of its next-generation electric motorcycles on track. "We're thrilled to retain the same passionate team that helped make Energica a recognized name in electric performance motorcycles," the company shared. "This transition isn't the end of the road - it's a fresh start. We remain fully committed to our customers, our community, and the mission to lead the future of electric mobility." Energica Motorcycles To view an enhanced version of this graphic, please visit: The judicial sale process, a form of legal restructuring, is expected to be finalized within the next 60 days. During this period, the company will begin implementing strategic steps to stabilize and strengthen its operations. According to insiders, Energica will prioritize rebuilding relationships with distributors and commercial partners, reestablishing supply chain consistency, and reinforcing customer support channels. The new ownership group is also expected to inject fresh capital and potentially expand the company's reach in key global markets, particularly in Asia, where demand for high-end electric two-wheelers is rising. Energica, based in Modena - a region globally revered for Italian automotive craftsmanship - is known for producing premium electric motorcycles that combine speed, sustainability, and cutting-edge technology. With this acquisition, the company appears poised to regain its momentum and play a significant role in the next era of electric transportation. About Energica Motor Company Energica is an Italian manufacturer of high-performance electric motorcycles. The company has built a global reputation for producing sustainable, technologically advanced two-wheelers that offer both exhilarating performance and environmental responsibility. Visit:
